.svg){kind=small}
71 participants from 12 countries helped make this international workshop focused on bridging strategies from early development to regulatory approval a resounding success. The workshop featured an outstanding speaker panel of experts from industry, academics and the MHRA.Many of the current issues and challenges in the development of both innovative and generic topically applied drug products were addressed.Watch our latest video on our experience in dermatology studies
.avif)
Latest news
Accelerated Pathways: How ILAP Gives Developers a Strategic Early Advantage
January 29, 2026
The pace of medical innovation is faster than ever, but patients often face delays in accessing transformative therapies.
Read moreEvents
Clinical Trials Innovation Programme
10 - 11 February 2026
Richmond Pharmacology is pleased to attend the Clinical Trials Innovation Programme Conference in Nice, France, 10–11 February 2026.
View event
